4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-049168
CHIEF EXECUTIVE OFFICER bought 14,000 shares at $0.74 ($10,315)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER | 2022-09-07 | Purchase | +14,000 | $0.74 | $10,315 | 5,230,564 | D |
| Open-market purchases · 14,000 sh · avg $0.74 · $10,315 | |||||||
Loading xslF345X03/doc4.xml…